World's Best Scientists 2026 revealed!
Jann N. Sarkaria

Jann N. Sarkaria

D-Index & Metrics

Medicine

D-Index
91
Citations
37728
World Ranking
11600
National Ranking
5952

Jann N. Sarkaria publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jann N. Sarkaria sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 913 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jann N. Sarkaria D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jann N. Sarkaria sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jann N. Sarkaria is a researcher affiliated with the Mayo Clinic in the United States. Their work spans multiple fields within medicine and biochemistry, genetics, and molecular biology, focusing primarily on molecular biology, genetics, oncology, radiology, nuclear medicine and imaging, as well as pulmonary and respiratory medicine.

The scientist's research addresses various topics related to cancer, particularly glioma diagnosis and treatment, DNA repair mechanisms, and cancer-related molecular pathways. Other notable areas include cancer, hypoxia, and metabolism, brain metastases and treatment, cancer research and treatments, and radiomics and machine learning in medical imaging.

Among recent publications, these papers are notable:

  • Purine metabolism regulates DNA repair and therapy resistance in glioblastoma, 2020, published in Nature Communications
  • Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance, 2021, published in Oncogene
  • Peak learning of mass spectrometry imaging data using artificial neural networks, 2021, published in Nature Communications
  • Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations, 2022, published in Journal of Clinical Oncology
  • ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL, 2020, published in Nature Communications

Frequent co-authors collaborating with this researcher include William F. Elmquist, Danielle M. Burgenske, Brett L. Carlson, Katrina K. Bakken, and Ann C. Mladek.

The researcher has a substantial presence in various scientific journals, with frequent publications in:

  • Neuro-Oncology (68 publications)
  • Cancer Research (28 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (24 publications)
  • Neuro-Oncology Advances (13 publications)
  • Molecular Cancer Therapeutics (9 publications)

Jann N. Sarkaria's work contributes to a comprehensive understanding of molecular mechanisms relevant to cancer biology and treatment, emphasizing both experimental and clinical aspects. Their research integrates molecular biology techniques, genetics, and advanced imaging and computational methods to explore therapeutic resistance, tumor plasticity, and metastatic processes.

Best Publications

  • Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

    Roel G. W. Verhaak;Katherine A. Hoadley;Elizabeth Purdom;Victoria Wang

  • The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression.

    Kui Ming Chan;Dong Fang;Haiyun Gan;Rintaro Hashizume

  • Inhibition of Phosphoinositide 3-Kinase Related Kinases by the Radiosensitizing Agent Wortmannin

    Jann N. Sarkaria;Randal S. Tibbetts;Ericka C. Busby;Amy P. Kennedy

  • Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells

    Anand G. Patel;Jann N. Sarkaria;Scott H. Kaufmann

  • Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.

    Jann N Sarkaria;Leland S Hu;Ian F Parney;Deanna H Pafundi

  • Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake

    William A Flavahan;Qiulian Wu;Masahiro Hitomi;Nasiha Rahim

  • The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1.

    Ericka C. Busby;Dru F. Leistritz;Robert T. Abraham;Larry M. Karnitz

  • Mechanisms of Chemoresistance to Alkylating Agents in Malignant Glioma

    Jann N. Sarkaria;Gaspar J. Kitange;C. David James;Ruth Plummer

  • THE ADVERSE EFFECT OF TREATMENT PROLONGATION IN CERVICAL CARCINOMA

    Daniel G. Petereit;Jann N. Sarkaria;Richard Chappell;John F. Fowler

  • Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts

    Gaspar J. Kitange;Brett L. Carlson;Mark A. Schroeder;Patrick T. Grogan

  • Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.

    Caterina Giannini;Jann N. Sarkaria;Atsushi Saito;Joon H. Uhm

  • WWP2 is an E3 ubiquitin ligase for PTEN.

    Subbareddy Maddika;Sridhar Kavela;Neelam Rani;Vivek Reddy Palicharla

  • Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177

    Paul D. Brown;Sunil Krishnan;Jann N. Sarkaria;Wenting Wu

  • Use of an Orthotopic Xenograft Model for Assessing the Effect of Epidermal Growth Factor Receptor Amplification on Glioblastoma Radiation Response

    Jann N. Sarkaria;Brett L. Carlson;Mark A. Schroeder;Patrick Grogan

  • Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy.

    Jeffrey S. Eshleman;Brett L. Carlson;Ann C. Mladek;Brian D. Kastner

  • Oral tongue cancer in young adults less than 40 years of age: rationale for aggressive therapy.

    Jann N. Sarkaria;Paul M. Harari

  • Establishment, maintenance and in vitro and in vivo applications of primary human glioblastoma multiforme (GBM) xenograft models for translational biology studies and drug discovery.

    Brett L. Carlson;Jenny L. Pokorny;Mark A. Schroeder;Jann N. Sarkaria

  • Strategies to improve delivery of anticancer drugs across the blood–brain barrier to treat glioblastoma

    Rajneet K. Oberoi;Karen E. Parrish;Terence T. Sio;Rajendar K. Mittapalli

  • Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines

    A. Peasland;L. Z. Wang;E. Rowling;S. Kyle

  • Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel

    Jann N. Sarkaria;Lin Yang;Patrick T. Grogan;Gaspar J. Kitange

Frequent Co-Authors

Evanthia Galanis
Evanthia Galanis Mayo Clinic
C. David James
C. David James Northwestern University
Jan C. Buckner
Jan C. Buckner Mayo Clinic
Paul D. Brown
Paul D. Brown Mayo Clinic
Marc Symons
Marc Symons Feinstein Institute for Medical Research
Brendan A.C. Harley
Brendan A.C. Harley University of Illinois at Urbana-Champaign

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative career paths in healthcare can open doors for students interested in the medical field but not pursuing a traditional MD. For instance, those interested in administrative roles may consider a health administration degree. These programs are available online and can lead to leadership positions in hospitals, clinics, and health organizations.

Allied health fields also offer accessible opportunities. If you prefer a program focused on insurance and medical records, there are online medical billing and coding schools that accept fafsa. These programs allow you to start your healthcare career quickly while potentially getting financial aid.

Pursuing nursing is another rewarding option. Some nursing schools that don't require teas or hesi exams make entry easier for aspiring nurses. Already a nurse with an ADN? You can advance your career through adn to msn bridge programs, designed for licensed nurses seeking higher degrees.

Best Scientists Citing Jann N. Sarkaria

Trending Scientists

Recently Published Articles